These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28468916)

  • 1. Tumor-Derived α-Fetoprotein Directly Drives Human Natural Killer-Cell Activation and Subsequent Cell Death.
    Vujanovic L; Stahl EC; Pardee AD; Geller DA; Tsung A; Watkins SC; Gibson GA; Storkus WJ; Butterfield LH
    Cancer Immunol Res; 2017 Jun; 5(6):493-502. PubMed ID: 28468916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived α-fetoprotein impairs the differentiation and T cell stimulatory activity of human dendritic cells.
    Pardee AD; Shi J; Butterfield LH
    J Immunol; 2014 Dec; 193(11):5723-32. PubMed ID: 25355916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells.
    Li C; Song B; Santos PM; Butterfield LH
    Cell Immunol; 2019 Jan; 335():59-67. PubMed ID: 30392891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
    González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
    Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Fetoprotein impairs activation of natural killer cells by inhibiting the function of dendritic cells.
    Yamamoto M; Tatsumi T; Miyagi T; Tsunematsu H; Aketa H; Hosui A; Kanto T; Hiramatsu N; Hayashi N; Takehara T
    Clin Exp Immunol; 2011 Aug; 165(2):211-9. PubMed ID: 21592114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory impact of α-fetoprotein.
    Munson PV; Adamik J; Butterfield LH
    Trends Immunol; 2022 Jun; 43(6):438-448. PubMed ID: 35550875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.
    Sung PS; Jang JW
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma.
    Kamiya T; Chang YH; Campana D
    Cancer Immunol Res; 2016 Jul; 4(7):574-81. PubMed ID: 27197065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma.
    Pardee AD; Yano H; Weinstein AM; Ponce AA; Ethridge AD; Normolle DP; Vujanovic L; Mizejewski GJ; Watkins SC; Butterfield LH
    J Immunother Cancer; 2015; 3():32. PubMed ID: 26199728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions.
    Wu Y; Kuang DM; Pan WD; Wan YL; Lao XM; Wang D; Li XF; Zheng L
    Hepatology; 2013 Mar; 57(3):1107-16. PubMed ID: 23225218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natural killer cell activity of the peripheral blood in patients with hepatocellular carcinoma].
    Lin ZY; Weng HZ; Tang ZY; Wang QD
    Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):417-20. PubMed ID: 2438105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
    Jiang W; Zhang C; Tian Z; Zhang J
    Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.
    Wang X; Wang Q
    Can J Gastroenterol Hepatol; 2018; 2018():9049252. PubMed ID: 29805966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma.
    Armeanu S; Krusch M; Baltz KM; Weiss TS; Smirnow I; Steinle A; Lauer UM; Bitzer M; Salih HR
    Clin Cancer Res; 2008 Jun; 14(11):3520-8. PubMed ID: 18519785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
    Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
    Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.
    Jinushi M; Takehara T; Tatsumi T; Hiramatsu N; Sakamori R; Yamaguchi S; Hayashi N
    J Hepatol; 2005 Dec; 43(6):1013-20. PubMed ID: 16168521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.
    Sui Q; Zhang J; Sun X; Zhang C; Han Q; Tian Z
    J Immunol; 2014 Aug; 193(4):2016-23. PubMed ID: 25015826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Transcatheter Arterial Chemoembolization Combined with Argon-Helium Cryosurgery System on the Changes of NK Cells and T Cell Subsets in Peripheral Blood of Hepatocellular Carcinoma Patients.
    Huang M; Wang X; Bin H
    Cell Biochem Biophys; 2015 Dec; 73(3):787-92. PubMed ID: 27259326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients.
    Bray SM; Vujanovic L; Butterfield LH
    Clin Dev Immunol; 2011; 2011():249281. PubMed ID: 21969837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-infiltrating CD11b
    Zhang QF; Yin WW; Xia Y; Yi YY; He QF; Wang X; Ren H; Zhang DZ
    Cell Mol Immunol; 2017 Oct; 14(10):819-829. PubMed ID: 27321064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.